Autopsy report · NCT05252910
Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents
Cause of deathSlow enrollment
“Global spread of SARS-CoV-2 Omicron variant and vaccination preclude ability to enroll sufficient SARS-CoV-2 seronegative participants.”
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 2 months before it stopped.
- 33 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Pharm-Olam, LLC
- Sponsor type
- Industry
- Conditions
- COVID-19
- Participants
- 33
- Sites
- 32
- Countries
- Colombia, Guadeloupe, India, Mexico, Puerto Rico, South Africa, United States
Trials that died the same way
- Respiratory Muscle Training in Stroke Swallowing Disorders
“Because of the SARS-COV2 pandemic. Recruitment stopped at 48 patients” - Pre Bypass Ultrafiltration (PBUF) in Children Requiring Cardiopulmonary Bypass
“Given SARS CoV2 pandemic, we had difficulty enrolling patients in the proposed time frame” - Treatment of Adults With Generalized Anxiety Disorder Using Glutamine
“Inhability to recruit further participants due to SARS-CoV-2 pandemics.” - Clinical Study of PGT-A Versus PGT-A+ERA
“Low recruitment speed, higher percentage drop-out and SARS-CoV-2 pandemic situation” - Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients
“the emergence of the omicron variant of COVID-19 lead to insufficient enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.